© Reuters. PHOTO: Candidate for Commissioner for Food and Drug Administration Dr. Robert Califf testifies at the Senate Committee on Health, Education, Labor and Pensions appointment at Capitol Hill, Washington, DC, November 17, 2015. REUTERS / Gary Cameron / Fil
WASHINGTON (Reuters) – U.S. Sen. Bernie Sanders said Tuesday he would oppose President Joe Biden’s nominee for Food and Drug Administration commissioner, Robert Califf, over his ties to the pharmaceutical industry.
“The COVID-19 pandemic has made the choice between pharmaceutical profits and the health of our people clearer than ever. At this critical time, Dr. Califf is not the leader Americans need in the FDA and I will oppose his nomination,” Sanders said in a statement. .
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage resulting from reliance on information including data, quotations, charts and buy / sell signals contained on this website. Please be fully informed about the risks and costs associated with trading in financial markets, this is one of the riskiest possible forms of investment.